We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under-recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.
|Journal||Clinical Case Reports|
|Publication status||Published - Jun 2021|
- adrenal insufficiency
- fever of unknown origin
- immune-related adverse events
- programmed cell death 1 protein inhibitor
ASJC Scopus subject areas